These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31532339)

  • 1. Optimising opioid substitution therapy in the prison environment.
    Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
    Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessing opioid agonist treatment in prison in England and Scotland remains problematic - the views of people with lived experience.
    Webster R; Fearns C; Harriott P; Millar L; Simpson J; Wallace J; Wheatley M
    Int J Prison Health (2024); 2024 May; 20(2):143-155. PubMed ID: 38984599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review.
    Loh DA; Plugge E; Van Hout MC
    Int J Drug Policy; 2023 Feb; 112():103957. PubMed ID: 36693296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
    Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L
    Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
    Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
    Larney S; Toson B; Burns L; Dolan K
    Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.
    Bachireddy C; Bazazi AR; Kavasery R; Govindasamy S; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2011 Jul; 116(1-3):151-7. PubMed ID: 21232882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007-2013.
    Larney S; Lai W; Dolan K; Zador D
    J Subst Abuse Treat; 2016 Nov; 70():58-63. PubMed ID: 27692189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
    Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
    Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Dutch national guidelines--pharmacological care for detained opioid addicts.
    Arends MT; De Haan HA; Van 't Hoff GI
    Int J Prison Health; 2009; 5(4):192-200. PubMed ID: 25757520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release.
    Bird SM; Fischbacher CM; Graham L; Fraser A
    Addiction; 2015 Oct; 110(10):1617-24. PubMed ID: 25940815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.
    Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL
    Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid substitution therapy for people living in German prisons-inequality compared with civic sector.
    Stöver H; Jamin D; Michels II; Knorr B; Keppler K; Deimel D
    Harm Reduct J; 2019 Dec; 16(1):72. PubMed ID: 31864356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
    Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S
    Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.
    Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L
    Addiction; 2014 Aug; 109(8):1306-17. PubMed ID: 24612249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.